Richardpruen (talk | contribs) (Marked this version for translation) |
(adding content) |
||
| (One intermediate revision by the same user not shown) | |||
| Line 241: | Line 241: | ||
===2016 [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940751/ Reductions in biomarkers of exposure, impacts on smoking urge and assessment of product use and tolerability in adult smokers following partial or complete substitution of cigarettes with electronic cigarettes]=== | ===2016 [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940751/ Reductions in biomarkers of exposure, impacts on smoking urge and assessment of product use and tolerability in adult smokers following partial or complete substitution of cigarettes with electronic cigarettes]=== | ||
*Subjects switching to e-cigarettes had significantly lower levels (29 %–95 %) of urinary [[Special:MyLanguage/Abbreviations|BoE]]s after 5 days. Nicotine equivalents declined by 25 %–40 %. | *Subjects switching to e-cigarettes had significantly lower levels (29 %–95 %) of urinary [[Special:MyLanguage/Abbreviations|BoE]]s after 5 days. Nicotine equivalents declined by 25 %–40 %. | ||
*Dual users who substituted half of their self-reported daily cigarette consumption with e-cigarettes experienced 7 %–38 % reductions, but had increases (1 %–20 %) in nicotine equivalents. | *Dual users who substituted half of their self-reported daily cigarette consumption with e-cigarettes experienced 7 %–38 % reductions, but had increases (1 %–20 %) in nicotine equivalents. | ||
| Line 252: | Line 250: | ||
*[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940751/pdf/12889_2016_Article_3236.pdf PDF Version] | *[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940751/pdf/12889_2016_Article_3236.pdf PDF Version] | ||
*Citation: D'Ruiz CD, Graff DW, Robinson E. Reductions in biomarkers of exposure, impacts on smoking urge and assessment of product use and tolerability in adult smokers following partial or complete substitution of cigarettes with electronic cigarettes. BMC Public Health. 2016 Jul 11;16:543. doi: 10.1186/s12889-016-3236-1. PMID: 27401980; PMCID: PMC4940751. | *Citation: D'Ruiz CD, Graff DW, Robinson E. Reductions in biomarkers of exposure, impacts on smoking urge and assessment of product use and tolerability in adult smokers following partial or complete substitution of cigarettes with electronic cigarettes. BMC Public Health. 2016 Jul 11;16:543. doi: 10.1186/s12889-016-3236-1. PMID: 27401980; PMCID: PMC4940751. | ||
*Acknowledgement: This study was funded by Fontem Ventures B.V., a fully owned subsidiary of Imperial Brands plc, and the manufacturer of the e-cigarette products used in this study. | *Acknowledgement: This study was funded by Fontem Ventures B.V., a fully owned subsidiary of Imperial Brands plc, and the manufacturer of the e-cigarette products used in this study. | ||
===2016 [https://www.sciencedirect.com/science/article/pii/S1383571816301711?via%3Dihub The mutagenic assessment of an electronic-cigarette and reference cigarette smoke using the Ames assay in strains TA98 and TA100]=== <!--T:45--> | ===2016 [https://www.sciencedirect.com/science/article/pii/S1383571816301711?via%3Dihub The mutagenic assessment of an electronic-cigarette and reference cigarette smoke using the Ames assay in strains TA98 and TA100]=== <!--T:45--> | ||
| Line 525: | Line 521: | ||
=Suggested studies to add to this page= <!--T:93--> | =Suggested studies to add to this page= <!--T:93--> | ||
===2022: REPLICA Project: [https://www.biorxiv.org/content/10.1101/2022.10.28.514205v1 In Vitro Toxicity Profile of myblu™ electronic cigarette Aerosol Compared to Cigarette Smoke: the REPLICA project]=== | |||
edits